Search Results | DrugBank Online

Displaying drugs 1151 - 1175 of 1338 in total

Tolperisone is an oral, centrally acting muscle relaxant. Its precise mechanism is not completely understood, though it blocks sodium and calcium channels. It possesses a high affinity for nervous system tissue, reaching highest concentrations in brain stem, spinal cord and peripheral nerves. Based on existing clinical data, Tolperisone is not...

Investigational

Matched Description: … Its precise mechanism is not completely understood, though it blocks sodium and calcium channels. ... It possesses a high affinity for nervous system tissue, reaching highest concentrations in brain stem …

Amrubicin

Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January...

Investigational

Matched Categories: … Calcium Homeostasis …

Advanced Filter

Filter by Group

Filter by Market Availability

Carboxylic PRPP

Tolperisone

Amrubicin

Nicotinamide adenine dinucleotide cyclohexanone

Methacrylyl-Coenzyme A

Propanoyl-CoA

CoA-s-acetyl tryptamine

3-Hydroxybutyryl-Coenzyme A

4-hydroxyphenacyl coenzyme A

6-hydroxy-FAD

GDP-alpha-D-mannuronic acid

Cpad

Adenylosuccinic acid

(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate

2-Dimethylamino-Ethyl-Diphosphate

t-Butylhydroquinone

Nitromethyldethia coenzyme A

4-bromo-3-hydroxy-3-methyl butyl diphosphate

Deamido-Nad+

Evocalcet

Nicotinamide adenine dinucleotide 3-pentanone adduct

P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate

2,5-di-tert-butylhydroquinone

4-hydroxybenzoyl-CoA

4-(N,N-Dimethylamino)cinnamoyl-CoA